|
Volumn 50, Issue 6, 2006, Pages 2272-2273
|
First occurrence of a Pseudomonas aeruginosa isolate in the United States producing an IMP metallo-β-lactamase, IMP-18 [3]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMIKACIN;
AZTREONAM;
BETA LACTAM ANTIBIOTIC;
CEFEPIME;
CEFTAZIDIME;
CEFTRIAXONE;
GENTAMICIN;
IMIPENEM;
IMP 18 PROTEIN;
LEVOFLOXACIN;
METALLO BETA LACTAMASE;
MINOCYCLINE;
PIPERACILLIN PLUS TAZOBACTAM;
POLYMYXIN B;
SULTAMICILLIN;
TIGECYCLINE;
UNCLASSIFIED DRUG;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC SENSITIVITY;
BACTERIAL GENE;
BACTERIUM ISOLATE;
DRUG HYDROLYSIS;
ENZYME SYNTHESIS;
HUMAN;
LETTER;
MINIMUM INHIBITORY CONCENTRATION;
NONHUMAN;
NUCLEOTIDE SEQUENCE;
POLYMERASE CHAIN REACTION;
PRIORITY JOURNAL;
PROTEIN FAMILY;
PSEUDOMONAS AERUGINOSA;
UNITED STATES;
ANTI-BACTERIAL AGENTS;
BETA-LACTAM RESISTANCE;
BETA-LACTAMASES;
GENES, BACTERIAL;
IMIPENEM;
MICROBIAL SENSITIVITY TESTS;
PSEUDOMONAS AERUGINOSA;
TRACHEA;
UNITED STATES;
|
EID: 33744481534
PISSN: 00664804
EISSN: None
Source Type: Journal
DOI: 10.1128/AAC.01440-05 Document Type: Letter |
Times cited : (47)
|
References (6)
|